跳至主要内容
临床试验/JPRN-UMIN000005930
JPRN-UMIN000005930已完成3 期

Phase III study of S-1 plus intravenous and intraperitoneal paclitaxel versus S-1 plus cisplatin for gastric cancer with peritoneal metastasis - PHOENIX-GC trial

The University of Tokyo Hospital0 个研究点目标入组 180 人开始时间: 2011年7月7日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Metastasis to distant organ sites other than the ovary 2) Contraindication to S-1, cisplatin or paclitaxel 3) Apparent infection or inflammation 4) Severe heart disease 5) Severe complication 6) Massive ascites requiring drainage for palliation 7) Gastrointestinal tract bleeding requiring blood transfusion 8) Severe diarrhea (more than 4 times a day and/or watery) 9) Psychiatric disorder requiring medication 10) Other active concomitant malignancies 11) Pregnancy, breast feeding or intention to become pregnant 12) Judged inappropriate for this trial for other reasons

研究者

相似试验